Ask AI
S. 4535

FDASRA Act of 2022

Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022

This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sen. Burr, Richard [R-NC](R-NC)Sponsor
1committees2actions3related bills
  1. IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. IntroReferral10000

    Introduced in Senate

FDASRA Act of 2022 — Informed